Breast Cancer Update Home - Oncology Leader Commentary

Home: Oncology Leader Commentary: J. Michael Dixon, MD

Click on the topic below for comments by Dr J. Michael Dixon to comment on. You will also find links to related articles and clinical trials.

Breast cysts as a cancer risk factor
Biochemistry of breast cysts
Intratumoral estrogen levels in breast cancer
Neoadjuvant endocrine therapy
Response rates with neoadjuvant endocrine therapy
Time to response with neoadjuvant endocrine therapy
Randomized trials of neoadjuvant Arimidex
Response criteria with neoadjuvant therapy
Biologic effect of endocrine agents
Combining endocrine agents
Quality of life with neoadjuvant endocrine therapy
Neoadjuvant endocrine therapy of locally advanced breast cancer
Neoadjuvant therapy of inflammatory breast cancer
Neoadjuvant therapy of elderly patients
Timing of surgery after neoadjuvant therapy
Neoadjuvant therapy with aromatase inhibitors

Home

Patrick I. Borgen, MD

Aman Buzdar, MD

Nancy E. Davidson, MD

J. Michael Dixon, MD

Armando Giuliano, MD

I. Craig Henderson, MD

David Krag, MD

Gershon Locker, MD

Charles Loprinzi, MD

Richard Margolese, MD

Monica Morrow, MD

C Kent Osborne, MD

Sir Richard Peto, FRS

Kathy I. Pritchard, MD

John F. Robertson, MD,FRCS

Andrew D. Seidman, MD

George W. Sledge, MD

Home · Contact us

Terms of use and general disclaimer